Christos Kyratsous

Senior Vice President, Genetic Medicines, Internal, and Research · Regeneron Pharmaceuticals

Biopharmaceuticals

Christos Kyratsous is senior vice president of genetic medicines, internal and research at Regeneron Pharmaceuticals. He joined in 2011 and leads next-generation genetic therapeutic platforms and the company’s non-oncology therapeutic focus areas.

Last reviewed: Oct 21, 2026

Christos Kyratsous

Senior Vice President, Genetic Medicines, Internal, and Research Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Christos Kyratsous is senior vice president of genetic medicines, internal and research at Regeneron Pharmaceuticals. He joined in 2011 and leads next-generation genetic therapeutic platforms and the company’s non-oncology therapeutic focus areas.

Career Highlights

  • Joined Regeneron in 2011.
  • Leads development of next-generation genetic therapeutic platforms.
  • Heads non-oncology therapeutic focus areas.

Professional Journey

Kyratsous worked at the Howard Hughes Medical Institute and completed a postdoctoral fellowship at New York University before joining Regeneron in 2011.

He now serves as senior vice president of Genetic Medicines, Internal and Research. His responsibilities include development of next-generation genetic therapeutic platforms and leadership of the company’s non-oncology therapeutic focus areas.

His career connects doctoral training in microbiology with research across therapeutic areas and genetic medicines technology. The current company biography identifies both the platform development responsibility and the broader non-oncology research remit.

Education

Kyratsous earned a BS from Aristotle University of Thessaloniki in Greece and a PhD in microbiology from Columbia University.